Bg pattern

CINACALCET PHARMSOL 30 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CINACALCET PHARMSOL 30 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Leaflet:information for theuser

Cinacalcet PharmSol 30mg film-coated tablets EFG

Cinacalcet PharmSol 60mg film-coated tablets EFG

Cinacalcet PharmSol 90mg film-coated tablets EFG

Cinacalcet

Read the entire leaflet carefully before starting to take this medicine, as it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor, pharmacist, or nurse.
  • This medicine has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. See section 4.

Contents of the leaflet

  1. What is Cinacalcet PharmSol and what is it used for
  2. What you need to know before taking Cinacalcet PharmSol
  3. How to take Cinacalcet PharmSol
  4. Possible side effects
  5. Storage of Cinacalcet PharmSol
  6. Package contents and additional information

1. What is Cinacalcet PharmSol and what is it used for

Cinacalcet works by controlling the levels of parathyroid hormone (PTH), calcium, and phosphorus in your body, and it is used to treat disorders of the parathyroid glands. The parathyroid glands are four small glands located in the neck, near the thyroid gland, which produce parathyroid hormone (PTH).

Cinacalcet is used in adults:

  • to treat secondary hyperparathyroidism in adults with severe kidney disease who require dialysis to remove waste products from their blood.
  • to reduce high levels of calcium in the blood (hypercalcemia) in adult patients with parathyroid cancer.
  • to reduce high levels of calcium in the blood (hypercalcemia) in adult patients with primary hyperparathyroidism when parathyroid gland removal is not possible.

Cinacalcet is used in children between 3 years and less than 18 years:

  • to treat secondary hyperparathyroidism in patients with severe kidney disease who require dialysis to remove waste products from their blood, and whose disease is not controlled with other treatments.

In primary and secondary hyperparathyroidism, the parathyroid glands produce too much PTH. The term "primary" means that the hyperparathyroidism is not caused by any other disease, and "secondary" means that the hyperparathyroidism is caused by another disease, such as kidney disease. Both primary and secondary hyperparathyroidism can cause calcium loss from the bones, which can lead to bone pain and fractures, vascular and cardiac problems, kidney stones, mental illness, and coma.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Cinacalcet PharmSol

Do nottake Cinacalcet PharmSolif you are allergic to cinacalcet or any of the other ingredients of this medicine (listed in section 6).

Do not take cinacalcetif you have low levels of calcium in your blood. Your doctor will monitor your blood calcium levels.

Warnings and precautions

Consult your doctor, pharmacist, or nurse before starting to take Cinacalcet.

Before starting to take cinacalcet, inform your doctor if you have or have ever had:

  • seizures(attacks or crises). The risk of having seizures is higher in people who have already had them;
  • liver problems;
  • heart failure.

Cinacalcet reduces calcium levels. In adults and children treated with cinacalcet, life-threatening and fatal events associated with low calcium levels (hypocalcemia) have been reported.

Inform your doctor if you experience any of the following symptoms that may indicate low calcium levels: muscle spasms, contractions, or cramps, or numbness or tingling in the fingers of the hands, feet, or around the mouth, or seizures, confusion, or loss of consciousness while taking cinacalcet.

Low calcium levels can affect your heart rhythm. Inform your doctor if you experience unusually strong or fast heartbeats, if you have heart rhythm problems, or if you take medications that cause heart rhythm problems while taking cinacalcet.

For additional information, see section 4.

During treatment with cinacalcet, inform your doctor:

  • if you start or stop smoking, as it may affect the effect of cinacalcet.

Children and adolescents

Children under 18 years of age with parathyroid cancer or primary hyperparathyroidism should not take cinacalcet.

If you are being treated for secondary hyperparathyroidism, your doctor should monitor your calcium levels before starting treatment with cinacalcet and during treatment with cinacalcet. You should inform your doctor if you experience any of the symptoms related to low calcium levels described above.

It is essential that you take your dose of cinacalcet as directed by your doctor.

Other medicines and cinacalcet

Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medicine, particularly etelcalcetide or any other medicine that reduces calcium levels in your blood.

You should not receive cinacalcet with etelcalcetide.

Inform your doctor if you are taking the following medications.

Medicines like the following may alter the action of Cinacalcet:

  • medicines used to treat skinand fungal infections(ketoconazole, itraconazole, and voriconazole);
  • medicines used to treat bacterial infections(telithromycin, rifampicin, and ciprofloxacin);
  • a medicine used to treat HIVand AIDS(ritonavir);
  • a medicine used to treat depression(fluvoxamine).

Cinacalcet may alter the action of some medicines, such as:

  • medicines used to treat depression(amitriptyline, desipramine, nortriptyline, and clomipramine);
  • a medicine used to relieve cough(dextromethorphan);
  • medicines used to treat heart rhythm disorders(flecainide and propafenone);
  • a medicine used to treat high blood pressure(metoprolol).

Taking cinacalcet with food and drinks

Cinacalcet should be taken with food or shortly after eating.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Cinacalcet has not been studied in pregnant women. In case of pregnancy, your doctor may decide to change your treatment, as cinacalcet may be harmful to the unborn baby.

It is not known whether cinacalcet passes into breast milk. Your doctor will tell you whether you should stop breastfeeding or stop taking cinacalcet.

Driving and using machines

In patients taking cinacalcet, cases of dizziness and seizures have been reported. If you experience these effects, do not drive or use machines.

Cinacalcet PharmSol contains lactose and sodium

This medicine contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.

This medicine contains less than 23 mg of sodium (1 mmol) per film-coated tablet, which is essentially "sodium-free".

3. How to take Cinacalcet PharmSol

Follow the instructions for administration of this medicine exactly as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again. Your doctor will tell you how much cinacalcet you should take.

Cinacalcet should be taken orally, with food or shortly after eating. The tablets should be swallowed whole and not chewed, crushed, or divided.

Cinacalcet is also available as a granule in capsules for opening. Children who require doses below 30 mg or who cannot swallow tablets should receive cinacalcet granules.

Your doctor will perform regular blood tests during treatment to monitor your progress and, if necessary, adjust the dose you receive.

If the treatment is for secondary hyperparathyroidism

The usual initial dose of cinacalcet in adults is 30 mg (one tablet) once a day.

The usual initial dose of cinacalcet in children between 3 years and less than 18 years should not exceed 0.20 mg/kg body weight per day.

If the treatment is for parathyroid cancer or primary hyperparathyroidism

The usual initial dose of cinacalcet in adults is 30 mg (one tablet) twice a day.

If you take more cinacalcet than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service. Phone 915 620 420, indicating the medicine and the amount used. Possible signs of overdose include numbness or tingling around the mouth, muscle pain or cramps, and seizures.

If you forget to take cinacalcet

Do not take a double dose to make up for forgotten doses.

If you have forgotten to take a dose of cinacalcet, you should take the next dose at the usual time.

If you have any other questions about the use of this medicine, ask your doctor, pharmacist, or nurse.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone gets them.

Tell your doctor immediately:

  • If you notice numbness or tingling around the mouth, muscle pain or cramps, and seizures. These may be symptoms of low calcium levels (hypocalcemia).
  • If you notice swelling in the face, lips, mouth, tongue, or throat that can cause difficulty swallowing or breathing (angioedema).

Very common: may affect more than 1 in 10 people

  • nausea and vomiting. These side effects are usually mild and transient.

Common: may affect up to 1 in 10 people

  • dizziness
  • numbness or tingling (paresthesia)
  • loss (anorexia) or decreased appetite
  • muscle pain (myalgia)
  • weakness (asthenia)
  • rash
  • decreased testosterone levels
  • high potassium levels in the blood (hyperkalemia)
  • allergic reactions (hypersensitivity)
  • headache
  • seizures (crises or attacks)
  • low blood pressure (hypotension)
  • upper respiratory tract infections
  • difficulty breathing (dyspnea)
  • cough
  • stomach discomfort (dyspepsia)
  • diarrhea
  • abdominal pain, upper abdominal pain
  • constipation
  • muscle spasms
  • back pain
  • low calcium levels in the blood (hypocalcemia).

Not known: frequency cannot be estimated from the available data

  • Hives (urticaria)
  • Swelling of the face, lips, mouth, tongue, or throat that can cause difficulty swallowing or breathing (angioedema)
  • Unusually fast or strong heartbeat that may be associated with low calcium levels in your blood (QT prolongation and ventricular arrhythmia secondary to hypocalcemia).

In a small number of patients with heart failure, their disease and/or low blood pressure (hypotension) worsened after taking cinacalcet.

Reporting of side effects

If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: www.notificaRAM.es.

By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Cinacalcet PharmSol

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiration date stated on the carton and blister after EXP. The expiration date is the last day of the month indicated.

This medicine does not require special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Package contents and additional information

Composition of Cinacalcet PharmSol

  • The active substance is cinacalcet. Each film-coated tablet contains 30 mg, 60 mg, or 90 mg of cinacalcet (as hydrochloride).
  • The other excipients are:

Core of the tablet

Pregelatinized (partially) cornstarch

Microcrystalline cellulose (E460)

Sodium croscarmellose (E468)

Colloidal anhydrous silica (E551)

Magnesium stearate (E470b)

Coating

Hypromellose 15cP (E464)

Lactose monohydrate

Titanium dioxide (E171)

Triacetin

FD & C Blue No. 2/Aluminum carmine indigo lacquer (E132)

Yellow iron oxide (E172)

Appearance of the product and package contents

Cinacalcet PharmSol 30 mg: green, oblong, biconvex, film-coated tablet engraved with "30" on one side and smooth on the other.

Cinacalcet PharmSol 60 mg: green, oblong, biconvex, film-coated tablet engraved with "60" on one side and smooth on the other.

Cinacalcet PharmSol 90 mg: green, oblong, biconvex, film-coated tablet engraved with "90" on one side and smooth on the other.

Cinacalcet PharmSol is available in transparent blister packs of 30 mg, 60 mg, or 90 mg film-coated tablets.

Package size: 28 tablets per carton.

Marketing authorization holder and manufacturer:

Marketing authorization holder

PharmSol Europe Limited

The Victoria Centre Unit 2,

Lower Ground Floor,

Valletta Road, Mosta MST 9012,

MALTA

Manufacturer

Genepharm S.A.

18 km Marathon Avenue

153 51 Pallini

Greece

Or

Delorbis Pharmaceuticals Ltd

17 Athinon str.,

Ergates Industrial Area,

2643 Ergates,

Nicosia, Cyprus

This medicine is authorized in the Member States of the European Economic Area under the following names:

AustriaCinacalcet PharmSol 30 mg, 60 mg, and 90 mg film-coated tablets

CroatiaCinakalcet PharmSol 30 mg, 60 mg, 90 mg film-coated tablets

Czech RepublicCinacalcet PharmSol

HungaryCinacalcet PharmSol 30 mg, 60 mg, and 90 mg film-coated tablets

MaltaCinacalcet PharmSol 30 mg, 60 mg, and 90 mg film-coated tablets

Slovak RepublicCinacalcet PharmSol 30 mg, 60 mg, and 90 mg film-coated tablets

SloveniaCinakalcet PharmSol 30 mg, 60 mg, and 90 mg film-coated tablets

SpainCinacalcet PharmSol 30 mg, 60 mg, and 90 mg film-coated tablets EFG

Date of last revision of this leaflet:November 2020

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es

Online doctors for CINACALCET PHARMSOL 30 mg FILM-COATED TABLETS

Discuss questions about CINACALCET PHARMSOL 30 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60
5.0 (29)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for CINACALCET PHARMSOL 30 mg FILM-COATED TABLETS?
CINACALCET PHARMSOL 30 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in CINACALCET PHARMSOL 30 mg FILM-COATED TABLETS?
The active ingredient in CINACALCET PHARMSOL 30 mg FILM-COATED TABLETS is cinacalcet. This information helps identify medicines with the same composition but different brand names.
Who manufactures CINACALCET PHARMSOL 30 mg FILM-COATED TABLETS?
CINACALCET PHARMSOL 30 mg FILM-COATED TABLETS is manufactured by Pharmsol Europe Limited. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of CINACALCET PHARMSOL 30 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether CINACALCET PHARMSOL 30 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to CINACALCET PHARMSOL 30 mg FILM-COATED TABLETS?
Other medicines with the same active substance (cinacalcet) include CINACALCET ACCORDPHARMA 30 mg FILM-COATED TABLETS, CINACALCET ACCORDPHARMA 60 mg FILM-COATED TABLETS, CINACALCET ACCORDPHARMA 90 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media